Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by National University of Malaysia
Sponsor:
Collaborator:
Cytopeutics Sdn Bhd
Information provided by (Responsible Party):
Dr Norlinah Mohamed Ibrahim, National University of Malaysia
ClinicalTrials.gov Identifier:
NCT01461720
First received: October 25, 2011
Last updated: March 30, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)